Skip to content

Multicenter prospective observational study for the usefulness of geriatric assessment before chemotherapy in elderly patients with gastric cancer

Multicenter prospective observational study for the usefulness of geriatric assessment before chemotherapy in elderly patients with gastric cancer - GA study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048629
Enrollment
120
Registered
2022-08-09
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Sponsors

Okayama University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ECOG PS 0-2 Patients who are going to receive platinum combination chemotherapy Patients who have written informed consent Patients over 70 years old

Exclusion criteria

Exclusion criteria: Recurrent cases during preoperative or postoperative chemotherapy Cases of clinical trial Patients who can not understand disease condition due to severe cognitive impairment

Design outcomes

Primary

MeasureTime frame
Adverse event rates of grade 3-4 during first-line chemotherapy

Secondary

MeasureTime frame
RDI(Relative dose intensity) during first-line chemotherapy, overall survival (OS), progression free survival (PFS), overall response rate (ORR), time to treatment failure (TTF), and the relationship between GA scores and adverse events or treatment results

Countries

Japan

Contacts

Public ContactYoshiyasu Kono

Okayama University Hospital Gastroenterology

hxnwq178@yahoo.co.jp086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026